Press Releases - 2022-11-24

Date	Title	Company
24-Nov-2022	Homecare Dermatology Energy-based Devices Market Analysis, Recent Trends and Regional Growth Forecast by 2028	MARKITWIRED
24-Nov-2022	Endoscopy Fluid Management Systems Market predicted to expand at a 7.4% CAGR to reach a net worth of US$ 683 Mn by 2028	MARKITWIRED
24-Nov-2022	Pharma Grade Synthetic Camphor Market is projected to register the growth of 4.2% CAGR from 2022 to 2028 \| FMI	MARKITWIRED
24-Nov-2022	Digital Radiography Detectors Market to reach a valuation of US$ 2,713.7 Mn by 2026 \| Future Market Insights	MARKITWIRED
24-Nov-2022	Carpal Tunnel Release Systems Market to US$ 863.2 Mn by 2029 \| Get Insights FMI	MARKITWIRED
24-Nov-2022	Aortic Stents Grafts Market to reaching a valuation of around 2.8 Billion by 2028 \| FMI	MARKITWIRED
24-Nov-2022	HIV Antivirals Market is set to reach a valuation of US$ 30.6 Billion in 2022 \| Get Insights FMI	MARKITWIRED
24-Nov-2022	Disposable Medical Sensors Market is expected to reach US$ 9.4 Billion in 2026 \| Says FMI	MARKITWIRED
24-Nov-2022	Interferons Market is projected to reach US$ 13.8 Billion by 2032 \| Exclusive Report by FMI	MARKITWIRED
24-Nov-2022	IVD Antibodies Market reaching a valuation of nearly US$ 77 Billion by 2027 \| FMI	MARKITWIRED
24-Nov-2022	BC Platforms Partners with EU Funded, AI-Driven, Cancer Data Initiative	BC Platforms
24-Nov-2022	Research & Development roles driving jobs growth in Life Sciences arena	APSCo
24-Nov-2022	Besins Healthcare launches Dimetrum® (dienogest) 2mg for the treatment of endometriosis in the UK	Besins Healthcare UK
24-Nov-2022	Allero Therapeutics Receives EIC Horizon Grant to Advance Treatment of Celiac Disease	Allero Therapeutics
24-Nov-2022	SynBiotic SE attracts Canopy Growth founder Bruce Linton as Chairman of newly created Advisory Board	SynBiotic SE
24-Nov-2022	Magnesium Testing Reagents Market – Business Opportunities and Global Forecast to 2029	MARKITWIRED
24-Nov-2022	Asklepios Kliniken: Sound business performance in first nine months of 2022	Asklepios Kliniken
24-Nov-2022	Original-Research: M1 Kliniken AG (von First Berlin Equity Research GmbH)	M1 Kliniken AG
24-Nov-2022	SPRAVATO®▼ (esketamine) nasal spray data from the phase 3b ESCAPE-TRD study demonstrate superior efficacy compared to quetiapine extended-release in treatment-resistant major depressive disorder1	Janssen Pharmaceutical Companies of Johnson & Johnson
24-Nov-2022	Tiziana Announces Publication of a Peer-Reviewed Article on the Intranasal Administration of Foralumab Demonstrating Modulated Effector CD8+ T cell Function and an Induced T Cell Regulatory Response in Human Subjects	Tiziana Life Sciences Ltd.